Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan-based 7-day triple therapy vs omeprazole-based 14-day triple therapy for Helicobacter pylori infection
TCTR20210130003Phase 4Recruiting
- Sponsor
- Rajavithi Hospital
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vonoprazan, omeprazole in Helicobacter pylori infection, sponsored by Rajavithi Hospital. Started Nov 2019; status: recruiting.
02
Drugs
vonoprazanomeprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on TCTR20210130003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210130003.